Target Gene/Pathway Pathway / Gene
Search results
No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID |
---|---|---|---|---|---|
1 | African trypanosomiasis 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
IFNG [1] IFNG 💬
|
Emapalumab Emapalumab 💬
| Emapalumab | 049 [3] 49, 65, 107 💬
|
2 | African trypanosomiasis 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
IFNG [1] IFNG 💬
|
Fontolizumab Fontolizumab 💬
| Fontolizumab | 046 [1] 46 💬
|
3 | Allograft rejection 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
IFNG [1] IFNG 💬
|
Emapalumab Emapalumab 💬
| Emapalumab | 049 [3] 49, 65, 107 💬
|
4 | Allograft rejection 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
IFNG [1] IFNG 💬
|
Fontolizumab Fontolizumab 💬
| Fontolizumab | 046 [1] 46 💬
|
5 | Amoebiasis 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
IFNG [1] IFNG 💬
|
Emapalumab Emapalumab 💬
| Emapalumab | 049 [3] 49, 65, 107 💬
|
6 | Amoebiasis 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
IFNG [1] IFNG 💬
|
Fontolizumab Fontolizumab 💬
| Fontolizumab | 046 [1] 46 💬
|
7 | Antigen processing and presentation 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
IFNG [1] IFNG 💬
|
Emapalumab Emapalumab 💬
| Emapalumab | 049 [3] 49, 65, 107 💬
|
8 | Antigen processing and presentation 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
IFNG [1] IFNG 💬
|
Fontolizumab Fontolizumab 💬
| Fontolizumab | 046 [1] 46 💬
|
9 | Chagas disease 💬 3 genes, 3 drugs (DrugBank) and 10 diseases |
IFNG [1] IFNG 💬
|
Emapalumab Emapalumab 💬
| Emapalumab | 049 [3] 49, 65, 107 💬
|
10 | Chagas disease 💬 3 genes, 3 drugs (DrugBank) and 10 diseases |
IFNG [1] IFNG 💬
|
Fontolizumab Fontolizumab 💬
| Fontolizumab | 046 [1] 46 💬
|
11 | Chagas disease 💬 3 genes, 3 drugs (DrugBank) and 10 diseases |
IFNGR1 [2] IFNGR1, IFNGR2 💬
|
Interferon gamma-1b Interferon gamma-1b 💬
| Interferon gamma-1b | 018 [7] 18, 65, 85, 228, 299, 301, 326 💬
|
12 | Cytokine-cytokine receptor interaction 💬 3 genes, 3 drugs (DrugBank) and 10 diseases |
IFNG [1] IFNG 💬
|
Emapalumab Emapalumab 💬
| Emapalumab | 049 [3] 49, 65, 107 💬
|
13 | Cytokine-cytokine receptor interaction 💬 3 genes, 3 drugs (DrugBank) and 10 diseases |
IFNG [1] IFNG 💬
|
Fontolizumab Fontolizumab 💬
| Fontolizumab | 046 [1] 46 💬
|
14 | Cytokine-cytokine receptor interaction 💬 3 genes, 3 drugs (DrugBank) and 10 diseases |
IFNGR1 [2] IFNGR1, IFNGR2 💬
|
Interferon gamma-1b Interferon gamma-1b 💬
| Interferon gamma-1b | 018 [7] 18, 65, 85, 228, 299, 301, 326 💬
|
15 | Fluid shear stress and atherosclerosis 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
IFNG [1] IFNG 💬
|
Emapalumab Emapalumab 💬
| Emapalumab | 049 [3] 49, 65, 107 💬
|
16 | Fluid shear stress and atherosclerosis 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
IFNG [1] IFNG 💬
|
Fontolizumab Fontolizumab 💬
| Fontolizumab | 046 [1] 46 💬
|
17 | Graft-versus-host disease 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
IFNG [1] IFNG 💬
|
Emapalumab Emapalumab 💬
| Emapalumab | 049 [3] 49, 65, 107 💬
|
18 | Graft-versus-host disease 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
IFNG [1] IFNG 💬
|
Fontolizumab Fontolizumab 💬
| Fontolizumab | 046 [1] 46 💬
|
19 | Hepatitis C 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
IFNG [1] IFNG 💬
|
Emapalumab Emapalumab 💬
| Emapalumab | 049 [3] 49, 65, 107 💬
|
20 | Hepatitis C 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
IFNG [1] IFNG 💬
|
Fontolizumab Fontolizumab 💬
| Fontolizumab | 046 [1] 46 💬
|
21 | Herpes simplex virus 1 infection 💬 3 genes, 3 drugs (DrugBank) and 10 diseases |
IFNG [1] IFNG 💬
|
Emapalumab Emapalumab 💬
| Emapalumab | 049 [3] 49, 65, 107 💬
|
22 | Herpes simplex virus 1 infection 💬 3 genes, 3 drugs (DrugBank) and 10 diseases |
IFNG [1] IFNG 💬
|
Fontolizumab Fontolizumab 💬
| Fontolizumab | 046 [1] 46 💬
|
23 | Herpes simplex virus 1 infection 💬 3 genes, 3 drugs (DrugBank) and 10 diseases |
IFNGR1 [2] IFNGR1, IFNGR2 💬
|
Interferon gamma-1b Interferon gamma-1b 💬
| Interferon gamma-1b | 018 [7] 18, 65, 85, 228, 299, 301, 326 💬
|
24 | HIF-1 signaling pathway 💬 3 genes, 3 drugs (DrugBank) and 10 diseases |
IFNG [1] IFNG 💬
|
Emapalumab Emapalumab 💬
| Emapalumab | 049 [3] 49, 65, 107 💬
|
25 | HIF-1 signaling pathway 💬 3 genes, 3 drugs (DrugBank) and 10 diseases |
IFNG [1] IFNG 💬
|
Fontolizumab Fontolizumab 💬
| Fontolizumab | 046 [1] 46 💬
|
26 | HIF-1 signaling pathway 💬 3 genes, 3 drugs (DrugBank) and 10 diseases |
IFNGR1 [2] IFNGR1, IFNGR2 💬
|
Interferon gamma-1b Interferon gamma-1b 💬
| Interferon gamma-1b | 018 [7] 18, 65, 85, 228, 299, 301, 326 💬
|
27 | IL-17 signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
IFNG [1] IFNG 💬
|
Emapalumab Emapalumab 💬
| Emapalumab | 049 [3] 49, 65, 107 💬
|
28 | IL-17 signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
IFNG [1] IFNG 💬
|
Fontolizumab Fontolizumab 💬
| Fontolizumab | 046 [1] 46 💬
|
29 | Inflammatory bowel disease 💬 3 genes, 3 drugs (DrugBank) and 10 diseases |
IFNG [1] IFNG 💬
|
Emapalumab Emapalumab 💬
| Emapalumab | 049 [3] 49, 65, 107 💬
|
30 | Inflammatory bowel disease 💬 3 genes, 3 drugs (DrugBank) and 10 diseases |
IFNG [1] IFNG 💬
|
Fontolizumab Fontolizumab 💬
| Fontolizumab | 046 [1] 46 💬
|
31 | Inflammatory bowel disease 💬 3 genes, 3 drugs (DrugBank) and 10 diseases |
IFNGR1 [2] IFNGR1, IFNGR2 💬
|
Interferon gamma-1b Interferon gamma-1b 💬
| Interferon gamma-1b | 018 [7] 18, 65, 85, 228, 299, 301, 326 💬
|
32 | Influenza A 💬 3 genes, 3 drugs (DrugBank) and 10 diseases |
IFNG [1] IFNG 💬
|
Emapalumab Emapalumab 💬
| Emapalumab | 049 [3] 49, 65, 107 💬
|
33 | Influenza A 💬 3 genes, 3 drugs (DrugBank) and 10 diseases |
IFNG [1] IFNG 💬
|
Fontolizumab Fontolizumab 💬
| Fontolizumab | 046 [1] 46 💬
|
34 | Influenza A 💬 3 genes, 3 drugs (DrugBank) and 10 diseases |
IFNGR1 [2] IFNGR1, IFNGR2 💬
|
Interferon gamma-1b Interferon gamma-1b 💬
| Interferon gamma-1b | 018 [7] 18, 65, 85, 228, 299, 301, 326 💬
|
35 | JAK-STAT signaling pathway 💬 3 genes, 3 drugs (DrugBank) and 10 diseases |
IFNG [1] IFNG 💬
|
Emapalumab Emapalumab 💬
| Emapalumab | 049 [3] 49, 65, 107 💬
|
36 | JAK-STAT signaling pathway 💬 3 genes, 3 drugs (DrugBank) and 10 diseases |
IFNG [1] IFNG 💬
|
Fontolizumab Fontolizumab 💬
| Fontolizumab | 046 [1] 46 💬
|
37 | JAK-STAT signaling pathway 💬 3 genes, 3 drugs (DrugBank) and 10 diseases |
IFNGR1 [2] IFNGR1, IFNGR2 💬
|
Interferon gamma-1b Interferon gamma-1b 💬
| Interferon gamma-1b | 018 [7] 18, 65, 85, 228, 299, 301, 326 💬
|
38 | Kaposi sarcoma-associated herpesvirus infection 💬 1 gene, 1 drug (DrugBank) and 7 diseases |
IFNGR1 [1] IFNGR1 💬
|
Interferon gamma-1b Interferon gamma-1b 💬
| Interferon gamma-1b | 018 [7] 18, 65, 85, 228, 299, 301, 326 💬
|
39 | Leishmaniasis 💬 3 genes, 3 drugs (DrugBank) and 10 diseases |
IFNG [1] IFNG 💬
|
Emapalumab Emapalumab 💬
| Emapalumab | 049 [3] 49, 65, 107 💬
|
40 | Leishmaniasis 💬 3 genes, 3 drugs (DrugBank) and 10 diseases |
IFNG [1] IFNG 💬
|
Fontolizumab Fontolizumab 💬
| Fontolizumab | 046 [1] 46 💬
|
41 | Leishmaniasis 💬 3 genes, 3 drugs (DrugBank) and 10 diseases |
IFNGR1 [2] IFNGR1, IFNGR2 💬
|
Interferon gamma-1b Interferon gamma-1b 💬
| Interferon gamma-1b | 018 [7] 18, 65, 85, 228, 299, 301, 326 💬
|
42 | Malaria 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
IFNG [1] IFNG 💬
|
Emapalumab Emapalumab 💬
| Emapalumab | 049 [3] 49, 65, 107 💬
|
43 | Malaria 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
IFNG [1] IFNG 💬
|
Fontolizumab Fontolizumab 💬
| Fontolizumab | 046 [1] 46 💬
|
44 | Natural killer cell mediated cytotoxicity 💬 3 genes, 3 drugs (DrugBank) and 10 diseases |
IFNG [1] IFNG 💬
|
Emapalumab Emapalumab 💬
| Emapalumab | 049 [3] 49, 65, 107 💬
|
45 | Natural killer cell mediated cytotoxicity 💬 3 genes, 3 drugs (DrugBank) and 10 diseases |
IFNG [1] IFNG 💬
|
Fontolizumab Fontolizumab 💬
| Fontolizumab | 046 [1] 46 💬
|
46 | Natural killer cell mediated cytotoxicity 💬 3 genes, 3 drugs (DrugBank) and 10 diseases |
IFNGR1 [2] IFNGR1, IFNGR2 💬
|
Interferon gamma-1b Interferon gamma-1b 💬
| Interferon gamma-1b | 018 [7] 18, 65, 85, 228, 299, 301, 326 💬
|
47 | Necroptosis 💬 3 genes, 3 drugs (DrugBank) and 10 diseases |
IFNG [1] IFNG 💬
|
Emapalumab Emapalumab 💬
| Emapalumab | 049 [3] 49, 65, 107 💬
|
48 | Necroptosis 💬 3 genes, 3 drugs (DrugBank) and 10 diseases |
IFNG [1] IFNG 💬
|
Fontolizumab Fontolizumab 💬
| Fontolizumab | 046 [1] 46 💬
|
49 | Necroptosis 💬 3 genes, 3 drugs (DrugBank) and 10 diseases |
IFNGR1 [2] IFNGR1, IFNGR2 💬
|
Interferon gamma-1b Interferon gamma-1b 💬
| Interferon gamma-1b | 018 [7] 18, 65, 85, 228, 299, 301, 326 💬
|
50 | Osteoclast differentiation 💬 3 genes, 3 drugs (DrugBank) and 10 diseases |
IFNG [1] IFNG 💬
|
Emapalumab Emapalumab 💬
| Emapalumab | 049 [3] 49, 65, 107 💬
|
51 | Osteoclast differentiation 💬 3 genes, 3 drugs (DrugBank) and 10 diseases |
IFNG [1] IFNG 💬
|
Fontolizumab Fontolizumab 💬
| Fontolizumab | 046 [1] 46 💬
|
52 | Osteoclast differentiation 💬 3 genes, 3 drugs (DrugBank) and 10 diseases |
IFNGR1 [2] IFNGR1, IFNGR2 💬
|
Interferon gamma-1b Interferon gamma-1b 💬
| Interferon gamma-1b | 018 [7] 18, 65, 85, 228, 299, 301, 326 💬
|
53 | Pathways in cancer 💬 3 genes, 3 drugs (DrugBank) and 10 diseases |
IFNG [1] IFNG 💬
|
Emapalumab Emapalumab 💬
| Emapalumab | 049 [3] 49, 65, 107 💬
|
54 | Pathways in cancer 💬 3 genes, 3 drugs (DrugBank) and 10 diseases |
IFNG [1] IFNG 💬
|
Fontolizumab Fontolizumab 💬
| Fontolizumab | 046 [1] 46 💬
|
55 | Pathways in cancer 💬 3 genes, 3 drugs (DrugBank) and 10 diseases |
IFNGR1 [2] IFNGR1, IFNGR2 💬
|
Interferon gamma-1b Interferon gamma-1b 💬
| Interferon gamma-1b | 018 [7] 18, 65, 85, 228, 299, 301, 326 💬
|
56 | PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 3 genes, 3 drugs (DrugBank) and 10 diseases |
IFNG [1] IFNG 💬
|
Emapalumab Emapalumab 💬
| Emapalumab | 049 [3] 49, 65, 107 💬
|
57 | PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 3 genes, 3 drugs (DrugBank) and 10 diseases |
IFNG [1] IFNG 💬
|
Fontolizumab Fontolizumab 💬
| Fontolizumab | 046 [1] 46 💬
|
58 | PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 3 genes, 3 drugs (DrugBank) and 10 diseases |
IFNGR1 [2] IFNGR1, IFNGR2 💬
|
Interferon gamma-1b Interferon gamma-1b 💬
| Interferon gamma-1b | 018 [7] 18, 65, 85, 228, 299, 301, 326 💬
|
59 | Proteasome 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
IFNG [1] IFNG 💬
|
Emapalumab Emapalumab 💬
| Emapalumab | 049 [3] 49, 65, 107 💬
|
60 | Proteasome 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
IFNG [1] IFNG 💬
|
Fontolizumab Fontolizumab 💬
| Fontolizumab | 046 [1] 46 💬
|
61 | Rheumatoid arthritis 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
IFNG [1] IFNG 💬
|
Emapalumab Emapalumab 💬
| Emapalumab | 049 [3] 49, 65, 107 💬
|
62 | Rheumatoid arthritis 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
IFNG [1] IFNG 💬
|
Fontolizumab Fontolizumab 💬
| Fontolizumab | 046 [1] 46 💬
|
63 | Systemic lupus erythematosus 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
IFNG [1] IFNG 💬
|
Emapalumab Emapalumab 💬
| Emapalumab | 049 [3] 49, 65, 107 💬
|
64 | Systemic lupus erythematosus 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
IFNG [1] IFNG 💬
|
Fontolizumab Fontolizumab 💬
| Fontolizumab | 046 [1] 46 💬
|
65 | T cell receptor signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
IFNG [1] IFNG 💬
|
Emapalumab Emapalumab 💬
| Emapalumab | 049 [3] 49, 65, 107 💬
|
66 | T cell receptor signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
IFNG [1] IFNG 💬
|
Fontolizumab Fontolizumab 💬
| Fontolizumab | 046 [1] 46 💬
|
67 | TGF-beta signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
IFNG [1] IFNG 💬
|
Emapalumab Emapalumab 💬
| Emapalumab | 049 [3] 49, 65, 107 💬
|
68 | TGF-beta signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
IFNG [1] IFNG 💬
|
Fontolizumab Fontolizumab 💬
| Fontolizumab | 046 [1] 46 💬
|
69 | Th1 and Th2 cell differentiation 💬 3 genes, 3 drugs (DrugBank) and 10 diseases |
IFNG [1] IFNG 💬
|
Emapalumab Emapalumab 💬
| Emapalumab | 049 [3] 49, 65, 107 💬
|
70 | Th1 and Th2 cell differentiation 💬 3 genes, 3 drugs (DrugBank) and 10 diseases |
IFNG [1] IFNG 💬
|
Fontolizumab Fontolizumab 💬
| Fontolizumab | 046 [1] 46 💬
|
71 | Th1 and Th2 cell differentiation 💬 3 genes, 3 drugs (DrugBank) and 10 diseases |
IFNGR1 [2] IFNGR1, IFNGR2 💬
|
Interferon gamma-1b Interferon gamma-1b 💬
| Interferon gamma-1b | 018 [7] 18, 65, 85, 228, 299, 301, 326 💬
|
72 | Th17 cell differentiation 💬 3 genes, 3 drugs (DrugBank) and 10 diseases |
IFNG [1] IFNG 💬
|
Emapalumab Emapalumab 💬
| Emapalumab | 049 [3] 49, 65, 107 💬
|
73 | Th17 cell differentiation 💬 3 genes, 3 drugs (DrugBank) and 10 diseases |
IFNG [1] IFNG 💬
|
Fontolizumab Fontolizumab 💬
| Fontolizumab | 046 [1] 46 💬
|
74 | Th17 cell differentiation 💬 3 genes, 3 drugs (DrugBank) and 10 diseases |
IFNGR1 [2] IFNGR1, IFNGR2 💬
|
Interferon gamma-1b Interferon gamma-1b 💬
| Interferon gamma-1b | 018 [7] 18, 65, 85, 228, 299, 301, 326 💬
|
75 | Toxoplasmosis 💬 3 genes, 3 drugs (DrugBank) and 10 diseases |
IFNG [1] IFNG 💬
|
Emapalumab Emapalumab 💬
| Emapalumab | 049 [3] 49, 65, 107 💬
|
76 | Toxoplasmosis 💬 3 genes, 3 drugs (DrugBank) and 10 diseases |
IFNG [1] IFNG 💬
|
Fontolizumab Fontolizumab 💬
| Fontolizumab | 046 [1] 46 💬
|
77 | Toxoplasmosis 💬 3 genes, 3 drugs (DrugBank) and 10 diseases |
IFNGR1 [2] IFNGR1, IFNGR2 💬
|
Interferon gamma-1b Interferon gamma-1b 💬
| Interferon gamma-1b | 018 [7] 18, 65, 85, 228, 299, 301, 326 💬
|
78 | Tuberculosis 💬 3 genes, 3 drugs (DrugBank) and 10 diseases |
IFNG [1] IFNG 💬
|
Emapalumab Emapalumab 💬
| Emapalumab | 049 [3] 49, 65, 107 💬
|
79 | Tuberculosis 💬 3 genes, 3 drugs (DrugBank) and 10 diseases |
IFNG [1] IFNG 💬
|
Fontolizumab Fontolizumab 💬
| Fontolizumab | 046 [1] 46 💬
|
80 | Tuberculosis 💬 3 genes, 3 drugs (DrugBank) and 10 diseases |
IFNGR1 [2] IFNGR1, IFNGR2 💬
|
Interferon gamma-1b Interferon gamma-1b 💬
| Interferon gamma-1b | 018 [7] 18, 65, 85, 228, 299, 301, 326 💬
|
81 | Type I diabetes mellitus 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
IFNG [1] IFNG 💬
|
Emapalumab Emapalumab 💬
| Emapalumab | 049 [3] 49, 65, 107 💬
|
82 | Type I diabetes mellitus 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
IFNG [1] IFNG 💬
|
Fontolizumab Fontolizumab 💬
| Fontolizumab | 046 [1] 46 💬
|